IVIg: Clinical Trials

11 trials of IVIg, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown, 2 completed, 2 terminated, 2 withdrawn. 11 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 411Unknown 4, Completed 2, Terminated 2, Withdrawn 2, Not yet recruiting 1

Follow IVIg: new trials by email Literature Review of IVIg trials Research Report on IVIg

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mitigate Immune-Mediated Loss of Therapeutic Response to Asfotase Alfa (STRENSIQ®) for Hypophosphatasia
methotrexate, rituximab, bortezomib - Hypophosphatasia
Phase 4WithdrawnAlexion Pharmaceuticals, Inc.2026-07-292025-12-18
Non Inferiority KawasakI Trial With Anakinra
Anakinra, Intravenous Immunoglobulins, Human - Kawasaki Disease, Anakinra
Phase 4WithdrawnMeyer Children's Hospital IRCCS2026-04-012026-10-26
IVIG in Painful Sensory Neuropathy
Intravenous immunoglobulin, Placebo - Sensory Neuropathy, Small Fiber Neuropathy
Phase 4Not yet recruitingSorlandet Hospital HF202024-02-012023-12-27
Treating Donors With Intravenous Immunoglobulin to Reduce Donor-Derived Infections
IVIG - Viremia, Bacteremia
Phase 4UnknownShanghai Changzheng Hospital402023-04-012023-04-05
IVIG in Patients With Severe COVID-19 Requiring Mechanical Ventilation
IVIG - Covid19, SARS-CoV Infection
Phase 4UnknownSharp HealthCare102020-11-012020-11-04
Study of SOC Plus IVIG Compared to SOC Alone in the Treatment of COVID-19
Octagam - Sars-CoV2
Phase 4CompletedGeorge Sakoulas, MD342020-04-282021-06-25
A Study to Evaluate the Benefit of Octagam 5%® in Subjects With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)
IVIG - Pediatric Acute-Onset Neuropsychiatric Syndrome, Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections
Phase 4UnknownIMMUNOe Research Centers212017-11-242019-11-19
Immunotherapy in Intractable Cryptogenic Epilepsy Patients With Autoimmune Antibody
IVIG, Prednisolone - Epilepsy, Unspecified, Intractable
Phase 4UnknownSeoul National University Hospital402015-09-012016-03-01
A Double-Blind, Placebo Controlled Study of Intravenous Immunoglobulin for HIV-Associated Myelopathy
Intravenous Immunoglobulin, Placebo - HIV-associated Myelopathy
Phase 4TerminatedDavid M. Simpson122012-02-012018-04-13
Intravenous Immunoglobulin and Plasma Exchange in Myasthenia Gravis
IVIG, PLEX - Myasthenia Gravid
Phase 4CompletedUniversity Health Network, Toronto872007-03-012010-08-11
IVIG Versus Placebo for the Treatment of Patients With Severe C-Diff
intravenous immunoglobulin G (IVIG), Placebo - Clostridium Difficile-associated Diarrhea (CDAD)
Phase 4TerminatedUniversity of Pittsburgh142003-10-012016-10-25

Conditions studied

COVID-19 (2)  ·  Anxiety Disorders (1)  ·  Bacteremia (1)  ·  Coronavirus Infections (1)  ·  Epilepsy (1)  ·  Hypophosphatasia (1)  ·  Mucocutaneous Lymph Node Syndrome (1)  ·  Myasthenia Gravis (1)  ·  Nervous System Diseases (1)  ·  Neuromuscular Diseases (1)  ·  Obsessive-Compulsive Disorder (1)  ·  Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections (1)  ·  Pediatric acute-onset neuropsychiatric syndrome (1)  ·  Peripheral Nervous System Diseases (1)  ·  Polyneuropathies (1)

Sponsors

Alexion Pharmaceuticals, Inc. (1)  ·  David M. Simpson (1)  ·  George Sakoulas, MD (1)  ·  IMMUNOe Research Centers (1)  ·  Meyer Children's Hospital IRCCS (1)  ·  Seoul National University Hospital (1)  ·  Shanghai Changzheng Hospital (1)  ·  Sharp HealthCare (1)  ·  Sorlandet Hospital HF (1)  ·  University Health Network, Toronto (1)  ·  University of Pittsburgh (1)

Countries

United States (5)  ·  Canada (1)  ·  South Korea (1)

Top investigators

George Sakoulas, MD (2)  ·  David Barth, MD (1)  ·  David Simpson, MD (1)  ·  Gabriele Simonini, Prof (1)  ·  George L Arnold, MD (1)  ·  Isaac Melamed, MD (1)  ·  Sang Kun Lee, Professor (1)  ·  Vera Bril, BSc, MD, FRCPC (1)

Results publications

PMID 33601937